Reichman Amir
Transaction: 06/16/2026
BUY
Change
+400,000,000
Price
Not reported
Filing
06/18/2026
Type
BUY
Scinai Immunotherapeutics Ltd.
SCNI • Biotechnology
$1.86
▼ -0.09 (-4.62%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$106.02M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.28Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 26, 2026, 12:19 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.86
Change-4.62%
Shares Out57.00M
Market Cap$106.02M
Enterprise Value$103.83M
52W Range2.15 - 16.80
Beta2.08
P/E-40.11
P/S70.85
P/B9.04
P/FCF-14.08
EV/Sales69.38
Price$1.86
Change-4.62%
Shares Out57.00M
Market Cap$106.02M
Enterprise Value$103.83M
52W Range2.15 - 16.80
Beta2.08
P/E-40.11
P/S70.85
P/B9.04
P/FCF-14.08
EV/Sales69.38
EV/EBITDA-13.39
EV/FCF-13.79
Earnings Yield-2.49%
FCF Yield-7.10%
Dividend Yield0.00%
Gross Margin-2.02%
Oper. Margin-5.75%
Profit Margin-6.34%
Debt/Eq0.28
Current Ratio1.30
Quick Ratio1.30
Volume126.52K
Avg Volume417.92K
EPS Surprise-239.38
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Manageable debt level · 0.28Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
GERMAIN MARK
Transaction: 06/16/2026
BUY
Change
+120,000,000
Price
Not reported
Filing
06/18/2026
Type
BUY
Mark Elad
Transaction: 03/18/2026
OTHER
Change
+13,460,984
Price
Not reported
Filing
03/26/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Reichman Amir | BUY | +400,000,000 | Not reported | 06/16/2026 | 06/18/2026 |
| GERMAIN MARK | BUY | +120,000,000 | Not reported | 06/16/2026 | 06/18/2026 |
| Mark Elad | OTHER | +13,460,984 | Not reported | 03/18/2026 | 03/26/2026 |
| Mark Elad | OTHER | 0 | Not reported | 03/18/2026 | 03/26/2026 |
| Raviv Adi | OTHER | +48,200,000 | $0.00 | 03/18/2026 | 03/18/2026 |
| Raviv Adi | OTHER | +200,000 | Not reported | 03/18/2026 | 03/18/2026 |
| Reichman Amir | OTHER | +67,540,000 | Not reported | 03/18/2026 | 03/18/2026 |
| Reichman Amir | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Green Jay | OTHER | +48,200,000 | $0.00 | 03/18/2026 | 03/18/2026 |
| Green Jay | OTHER | +200,000 | Not reported | 03/18/2026 | 03/18/2026 |
| GERMAIN MARK | OTHER | +100,000,000 | $0.00 | 03/18/2026 | 03/18/2026 |
| Moed Samuel J | OTHER | +48,200,000 | $0.00 | 03/18/2026 | 03/18/2026 |
| Moed Samuel J | OTHER | +200,000 | Not reported | 03/18/2026 | 03/18/2026 |
| Ben-Or Uri | OTHER | +2,519,344 | Not reported | 03/18/2026 | 03/18/2026 |
| Ben-Or Uri | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| MARGOLIN YAEL | OTHER | +48,200,000 | $0.00 | 03/18/2026 | 03/18/2026 |
| MARGOLIN YAEL | OTHER | +200,000 | Not reported | 03/18/2026 | 03/18/2026 |
| BARRON PARTNERS LP | SELL | -547,323 | $0.46 | 09/28/2005 | 09/28/2005 |
| BARRON PARTNERS LP | SELL | -5,000 | $0.50 | 09/26/2005 | 09/26/2005 |
| BARRON PARTNERS LP | SELL | -5,000 | $0.51 | 09/23/2005 | 09/23/2005 |